| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Pimitespib | TAS-116 | Approved | Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd | Jeselhy, ジェセリ | Japan | Gastrointestinal Stromal Tumors | Taiho Pharmaceutical Co Ltd | 2022-08-01 | Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Head and Neck Neoplasms; Sarcoma, Alveolar Soft Part; Solid tumours; Stomach Neoplasms | Details |